Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ

Abstract Background Tumour-infiltrating lymphocytes (TILs) have been demonstrated to significantly influence prognosis and response to therapy of invasive breast cancer (IBC). Thus, it has been suggested that TIL density or/and immunophenotype could serve as biomarkers for selection of IBC patients...

Full description

Bibliographic Details
Main Authors: Marie Beguinot, Marie-Melanie Dauplat, Fabrice Kwiatkowski, Guillaume Lebouedec, Lucie Tixier, Christophe Pomel, Frederique Penault-Llorca, Nina Radosevic-Robin
Format: Article
Language:English
Published: BMC 2018-02-01
Series:BMC Cancer
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12885-018-4013-6
_version_ 1818291338245832704
author Marie Beguinot
Marie-Melanie Dauplat
Fabrice Kwiatkowski
Guillaume Lebouedec
Lucie Tixier
Christophe Pomel
Frederique Penault-Llorca
Nina Radosevic-Robin
author_facet Marie Beguinot
Marie-Melanie Dauplat
Fabrice Kwiatkowski
Guillaume Lebouedec
Lucie Tixier
Christophe Pomel
Frederique Penault-Llorca
Nina Radosevic-Robin
author_sort Marie Beguinot
collection DOAJ
description Abstract Background Tumour-infiltrating lymphocytes (TILs) have been demonstrated to significantly influence prognosis and response to therapy of invasive breast cancer (IBC). Thus, it has been suggested that TIL density or/and immunophenotype could serve as biomarkers for selection of IBC patients for immunotherapy. However, much less is known about significance of TILs in breast ductal carcinoma in situ (DCIS). Methods We retrospectively investigated TIL density and immunophenotype in 96 pure DCIS and 35 microinvasive carcinomas (miCa). TIL density was assessed on H&E-stained breast biopsy sections as the percentage of tumour stromal area occupied by TILs, and classified into 4 grades: 0 (0%–9%), 1 (10–29%), 2 (30–49%) and 3 (50%–100%). TIL immunophenotype was assessed by immunohistochemistry for CD8, CD4, FoxP3, CD38 or CD20. Results Compared to pure DCIS, miCa contained significantly more cases with TIL density grade 3 (p = 0.028). Concordantly, CD8+, CD4+ and CD38+ cells were more numerous in miCa than in pure DCIS. In the pure DCIS subgroup with TIL density grades 2 and 3, all TIL subpopulations were more numerous than in the pure DCIS with TIL density grades 0 and 1, however the ratio between T-lymphocytes (CD8+ and CD4+) and B-lymphocytes (CD20+) was significantly lower (p = 0.029). On the other side, this ratio was significantly higher in miCa, in comparison with pure DCIS having TIL density grades 2 and 3 (p = 0.017). By cluster analysis of tumour cell pathobiological features we demonstrated similarity between miCa and the pure DCIS with TIL density grades 2 and 3. The only significant difference between those two categories was in the ratio of T- to B-TILs, higher in miCa. Conclusion Results indicate that TIL density level can distinguish 2 biologically different DCIS subgroups, one of which (DCIS with ≥30% TILs, the TIL-rich DCIS) is like miCa. Similarity of TIL-rich pure DCIS and miCa as well as the role of B-lymphocytes in DCIS invasiveness are worth further investigating with regards to the potential development of immunotherapy-based prevention of DCIS progression.
first_indexed 2024-12-13T02:42:29Z
format Article
id doaj.art-c5ad628c979a4b1d90f99da8187ad503
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-12-13T02:42:29Z
publishDate 2018-02-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-c5ad628c979a4b1d90f99da8187ad5032022-12-22T00:02:16ZengBMCBMC Cancer1471-24072018-02-0118111010.1186/s12885-018-4013-6Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situMarie Beguinot0Marie-Melanie Dauplat1Fabrice Kwiatkowski2Guillaume Lebouedec3Lucie Tixier4Christophe Pomel5Frederique Penault-Llorca6Nina Radosevic-Robin7Department of Surgical Oncology, Jean Perrin Comprehensive Cancer CentreDepartment of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer CentreDepartment of Clinical Research, Jean Perrin Comprehensive Cancer CentreDepartment of Surgical Oncology, Jean Perrin Comprehensive Cancer CentreDepartment of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer CentreDepartment of Surgical Oncology, Jean Perrin Comprehensive Cancer CentreDepartment of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer CentreDepartment of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer CentreAbstract Background Tumour-infiltrating lymphocytes (TILs) have been demonstrated to significantly influence prognosis and response to therapy of invasive breast cancer (IBC). Thus, it has been suggested that TIL density or/and immunophenotype could serve as biomarkers for selection of IBC patients for immunotherapy. However, much less is known about significance of TILs in breast ductal carcinoma in situ (DCIS). Methods We retrospectively investigated TIL density and immunophenotype in 96 pure DCIS and 35 microinvasive carcinomas (miCa). TIL density was assessed on H&E-stained breast biopsy sections as the percentage of tumour stromal area occupied by TILs, and classified into 4 grades: 0 (0%–9%), 1 (10–29%), 2 (30–49%) and 3 (50%–100%). TIL immunophenotype was assessed by immunohistochemistry for CD8, CD4, FoxP3, CD38 or CD20. Results Compared to pure DCIS, miCa contained significantly more cases with TIL density grade 3 (p = 0.028). Concordantly, CD8+, CD4+ and CD38+ cells were more numerous in miCa than in pure DCIS. In the pure DCIS subgroup with TIL density grades 2 and 3, all TIL subpopulations were more numerous than in the pure DCIS with TIL density grades 0 and 1, however the ratio between T-lymphocytes (CD8+ and CD4+) and B-lymphocytes (CD20+) was significantly lower (p = 0.029). On the other side, this ratio was significantly higher in miCa, in comparison with pure DCIS having TIL density grades 2 and 3 (p = 0.017). By cluster analysis of tumour cell pathobiological features we demonstrated similarity between miCa and the pure DCIS with TIL density grades 2 and 3. The only significant difference between those two categories was in the ratio of T- to B-TILs, higher in miCa. Conclusion Results indicate that TIL density level can distinguish 2 biologically different DCIS subgroups, one of which (DCIS with ≥30% TILs, the TIL-rich DCIS) is like miCa. Similarity of TIL-rich pure DCIS and miCa as well as the role of B-lymphocytes in DCIS invasiveness are worth further investigating with regards to the potential development of immunotherapy-based prevention of DCIS progression.http://link.springer.com/article/10.1186/s12885-018-4013-6breastcancerductalin situmicroinvasivelymphocytes
spellingShingle Marie Beguinot
Marie-Melanie Dauplat
Fabrice Kwiatkowski
Guillaume Lebouedec
Lucie Tixier
Christophe Pomel
Frederique Penault-Llorca
Nina Radosevic-Robin
Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ
BMC Cancer
breast
cancer
ductal
in situ
microinvasive
lymphocytes
title Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ
title_full Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ
title_fullStr Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ
title_full_unstemmed Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ
title_short Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ
title_sort analysis of tumour infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ
topic breast
cancer
ductal
in situ
microinvasive
lymphocytes
url http://link.springer.com/article/10.1186/s12885-018-4013-6
work_keys_str_mv AT mariebeguinot analysisoftumourinfiltratinglymphocytesrevealstwonewbiologicallydifferentsubgroupsofbreastductalcarcinomainsitu
AT mariemelaniedauplat analysisoftumourinfiltratinglymphocytesrevealstwonewbiologicallydifferentsubgroupsofbreastductalcarcinomainsitu
AT fabricekwiatkowski analysisoftumourinfiltratinglymphocytesrevealstwonewbiologicallydifferentsubgroupsofbreastductalcarcinomainsitu
AT guillaumelebouedec analysisoftumourinfiltratinglymphocytesrevealstwonewbiologicallydifferentsubgroupsofbreastductalcarcinomainsitu
AT lucietixier analysisoftumourinfiltratinglymphocytesrevealstwonewbiologicallydifferentsubgroupsofbreastductalcarcinomainsitu
AT christophepomel analysisoftumourinfiltratinglymphocytesrevealstwonewbiologicallydifferentsubgroupsofbreastductalcarcinomainsitu
AT frederiquepenaultllorca analysisoftumourinfiltratinglymphocytesrevealstwonewbiologicallydifferentsubgroupsofbreastductalcarcinomainsitu
AT ninaradosevicrobin analysisoftumourinfiltratinglymphocytesrevealstwonewbiologicallydifferentsubgroupsofbreastductalcarcinomainsitu